A second national questionnaire survey of TMA

International Journal of Hematology

Volumn 92, Issue 1, 2010, Pages 68-75

  Ito Habe, Naomi ^a   Wada, Hideo ^a   Matsumoto, Masanori ^b   Fujimura, Yoshihiro ^b   Murata, Mitsuru ^c   Izuno, Takashi ^d   Sugita, Minoru ^e   Ikeda, Yasuo ^f  

^a MIE UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d Tokyo Metropolitan Government Tokyo Metropolitan Hospitals Association Patient Safety Management   (Japan)

^e TOHO UNIVERSITY   (Japan)

^f WASEDA UNIVERSITY   (Japan)

Author keywords

ADAMTS13; HUS; TMA; TTP

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; METHYLPREDNISOLONE; PROTEINASE INHIBITOR; STEROID; THROMBOCYTE CONCENTRATE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLLAGEN DISEASE; DRUG EFFICACY; DRUG RESPONSE; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; FEMALE; HEALTH SURVEY; HEMODIALYSIS; HUMAN; INFANT; JAPANESE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PLASMAPHERESIS; QUESTIONNAIRE; REMISSION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ESCHERICHIA COLI O157; HUMANS; JAPAN; QUESTIONNAIRES; REMISSION INDUCTION; THROMBOTIC MICROANGIOPATHIES; TREATMENT OUTCOME;

EID: 77955175561     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0599-4     Document Type: Article

References (29)

1. JL Moake 2002 Thrombotic microangiopathies N Engl J Med 347 589 600 10.1056/NEJMra020528 1:CAS:528:DC%2BD38Xmt1yit7Y%3D 12192020
2. JN George SK Vessely DR Terrell 2004 The Oklahoma thrombotic thrombocytopenic purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS Semin Hematol 41 60 67 10.1053/j.seminhematol.2003.10.001 14727260
3. EL Amorosi JE Ultman 1966 Thrombotic thrombocytopenic purpura: report of the 16 cases and review of the literature Medicine 45 139 159 10.1097/00005792-196603000-00003
4. M Matsumoto H Yagi H Ishizashi H Wada Y Fujimura 2004 The Japanese Experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Semin Hematol 41 68 74 10.1053/j.seminhematol.2003.10.009 14727261
5. A Pereira R Mazzara J Monteagudo C Sanz L Puig A Martínez A Ordinas R Castillo 1995 Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange Ann Hematol 70 319 323 10.1007/BF01696619 1:STN:280: DyaK2MzlvFaruw%3D%3D 7632812
6. JL Moake CK Rudy JH Troll MJ Weinstein NM Colannino J Azocar RH Seder SL Hong D Deykin 1982 Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura N Engl J Med 307 1432 1435 10.1056/NEJM198212023072306 1:STN:280:DyaL3s%2Fjs1yksA%3D%3D 6813740
7. TW Chow NA Turner M Chintagumpala PD McPherson LH Nolasco L Rice JD Hellums JL Moake 1998 Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura Am J Hematol 57 293 302 10.1002/(SICI)1096-8652(199804)57:4<293::AID-AJH5>3.0. CO;2-P 1:STN:280:DyaK1c3gsVGgtg%3D%3D 9544973
8. Y Asada A Sumiyoshi T Hayashi J Suzumiya K Kaketani 1985 Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen Thromb Res 38 469 479 10.1016/0049-3848(85)90180-X 1:STN:280:DyaL2M3ksFeqsA%3D%3D 2861671
9. K Soejima N Mimura M Hirashima H Maeda T Hamamoto T Nakagaki C Nozaki 2001 A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease? J Biochem 130 475 480 1:CAS:528:DC%2BD3MXovVCqtr0%3D 11574066
10. GG Levy WC Nichols EC Lian T Foroud JN McClintick BM McGee AY Yang DR Siemieniak KR Stark R Gruppo R Sarode SB Shurin V Chandrasekaran SP Stabler H Sabio EE Bouhassira JD Upshaw Jr D Ginsburg HM Tsai 2001 Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura Nature 413 488 494 10.1038/35097008 1:CAS:528:DC%2BD3MXnsFyit70%3D 11586351
11. X Zheng D Chung TK Takayama EM Majerus JE Sadler K Fujikawa 2001 Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura J Biol Chem 276 41059 41063 10.1074/jbc.C100515200 1:CAS:528:DC%2BD3MXosVKgsLw%3D 11557746
12. M Furlan R Robles B Lamie 1996 Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis Blood 87 4223 4234 1:CAS:528:DyaK28XivFGhtb4%3D 8639781
13. H-M Tsai 1996 Physiologic cleavage of von Willebrand factor by a plasma protease is depend on its conformation and requires calcium ion Blood 87 4235 4244 1:CAS:528:DyaK28XivFGhtb8%3D 8639782
14. G Rock 2005 The management of thrombotic thrombocytopenic purpura in 2005 Semin Thromb Hemost 31 709 716 10.1055/s-2005-925477 16388422
15. F Ozkalemkas R Ali V Ozkocaman T Ozcelik A Ozkan A Tunali 2007 Therapeutic plasma exchange plus corticosteroid for the treatment of the thrombotic thrombocytopenic purpura: a single institutional experience in the southern Marmara region of Turkey Transfus Apher Sci 36 109 115 10.1016/j.transci.2006.05.020 17291831
16. SJ Brunskill A Tusold S Benjamin SJ Stanworth MF Murphy 2007 A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura Transfus Med 17 17 35 10.1111/j.1365-3148. 2007.00786.x 1:STN:280:DC%2BD2s%2Fmt1WgsQ%3D%3D 17266701
17. SL Allford BJ Hunt P Rose SJ Machin 2003 Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology: Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias Br J Haematol 120 556 573 10.1046/j.1365-2141.2003.04049.x 12588343
18. Sugita M, Izumo T, Tamakoshi A, Nagai M, Inaba Y, Kurosawa M, Ikeda Y, Murata M, Fujimura Y, Miyata T, Wada H. Nationwide epidemiological survey of patients with thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). In: Nagai M, editor. 2006 Annual Report of Research on Measures for Intractable Diseases. Japan: The Ministry of Health, Labour and Welfare of Japan; 2007.
19. N Ito H Wada M Matsumoto Y Fujimura M Murata T Izuno M Sugita Y Ikeda 2009 National questionnaire survey of TMA Int J Hematol 90 328 335 10.1007/s12185-009-0421-3 19760483
20. K Kokame Y Nobe Y Kokubo A Okayama T Miyata 2005 FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay Br J Haematol 129 93 100 10.1111/j.1365-2141.2005.05420.x 1:CAS:528:DC%2BD2MXktVCgtrg%3D 15801961
21. S Kato M Matsumoto T Matsuyama A Isonishi H Hiura Y Fujimura 2006 Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity Transfusion 46 8 1444 1452 10.1111/j.1537-2995.2006.00914.x 1:CAS:528:DC%2BD28XpsFejtbw%3D 16934083
22. GA Rock 2000 Management of thrombocytopenic purpura Br J Haematol 109 496 507 10.1046/j.1365-2141.2000.01941.x 1:STN:280:DC%2BD3czksFequw%3D%3D 10886194
23. EC Lian 2005 Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond Semin Thromb Hemost 31 625 632 10.1055/s-2005-925468 1:CAS:528:DC%2BD28XptlSgsA%3D%3D 16388413
24. CE Thompson LE Damon CA Ries CA Linker 1992 Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic Blood 80 1890 1895 1:STN:280: DyaK3s%2FgsVOnuw%3D%3D 1391952
25. P Coppo D Bengoufa A Veyradier M Wolf A Bussel GA Millot S Malot F Heshmati JP Mira E Boulanger L Galicier MA Durey-Dragon V Fremeaux-Bacchi M Ramakers A Pruna D Bordessoule V Gouilleux ML Scrobohaci JP Vernant D Moreau E Azoulay B Schlemmer L Guillevin K Lassoued 2004 Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement Medicine (Baltimore) 83 233 244 10.1097/01.md.0000133622. 03370.07 1:CAS:528:DC%2BD2cXltlOkurc%3D
26. GA Rock KH Shumak NA Buskard VS Blanchette JG Kelton RC Nair RA Spasoff 1991 Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group N Engl J Med 325 393 397 10.1056/NEJM199108083250604 1:STN:280:DyaK3M3oslOnug%3D%3D 2062330
27. A Hattori W Tatewaki Japan TTP Research Group 1993 Treatment of TTP-retrospective analysis on Japanese patients and review Jpn J Clin Med 51 178 183 1:STN:280:DyaK3s7msVCksg%3D%3D
28. Verbeke L, Delforge M, Dierickx D. Current insight into thrombotic thrombocytopenic purpura. Blood Coagul Fibrinolysis. 2009 [Epub ahead of print].
29. Y Mori H Wada S Tamaki N Minami H Shiku T Ihara M Omine E Kakisita 1999 Outcome of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan Clin Appl Thromb Hemost 5 110 112 10.1177/107602969900500206 1:STN:280:DC%2BD3c7ptVWruw%3D%3D 10725990